List of Excipients in API ponatinib hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ponatinib hydrochloride
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Takeda Pharmaceuticals America Inc | ICLUSIG | ponatinib hydrochloride | 63020-535 | CELLULOSE, MICROCRYSTALLINE | |
Takeda Pharmaceuticals America Inc | ICLUSIG | ponatinib hydrochloride | 63020-535 | LACTOSE MONOHYDRATE | |
Takeda Pharmaceuticals America Inc | ICLUSIG | ponatinib hydrochloride | 63020-535 | MAGNESIUM STEARATE | |
Takeda Pharmaceuticals America Inc | ICLUSIG | ponatinib hydrochloride | 63020-535 | SILICON DIOXIDE | |
Takeda Pharmaceuticals America Inc | ICLUSIG | ponatinib hydrochloride | 63020-535 | SODIUM STARCH GLYCOLATE TYPE B POTATO | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ponatinib hydrochloride
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ponatinib hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | ponatinib hydrochloride | 63020-535 |
>Company | >Ingredient | >NDC |
ponatinib hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
ponatinib hydrochloride drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | ponatinib hydrochloride | 63020-535 |
>Company | >Ingredient | >NDC |
ponatinib hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ponatinib hydrochloride drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | ponatinib hydrochloride | 63020-535 |
>Company | >Ingredient | >NDC |
ponatinib hydrochloride drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ponatinib hydrochloride drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | ponatinib hydrochloride | 63020-535 |
>Company | >Ingredient | >NDC |
ponatinib hydrochloride drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
ponatinib hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | ponatinib hydrochloride | 63020-535 |
>Company | >Ingredient | >NDC |
ponatinib hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.